Oncoclinicas do Brasil (ONCO3) - Total Liabilities

Latest as of September 2025: R$7.02 Billion BRL ≈ $1.38 Billion USD

Based on the latest financial reports, Oncoclinicas do Brasil (ONCO3) has total liabilities worth R$7.02 Billion BRL (≈ $1.38 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ONCO3 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Oncoclinicas do Brasil - Total Liabilities Trend (2013–2024)

This chart illustrates how Oncoclinicas do Brasil's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Oncoclinicas do Brasil assets under control.

Oncoclinicas do Brasil Competitors by Total Liabilities

The table below lists competitors of Oncoclinicas do Brasil ranked by their total liabilities.

Company Country Total Liabilities
Gwangjushinseg
KO:037710
Korea ₩397.59 Billion
Deo Ca Traffic Infrastructure Investment JSC
VN:HHV
Vietnam ₫28.01 Trillion
Firm Capital Property Trust
TO:FCD-UN
Canada CA$331.88 Million
VAA Vista Alegre Atlantis SGPS SA
LS:VAF
Portugal €175.15 Million
P2 Gold Inc
V:PGLD
Canada CA$1.44 Million
Gofore Oyj
HE:GOFORE
Finland €109.24 Million
Asian Sea Corporation Public Company Limited
BK:ASIAN
Thailand ฿1.24 Billion
Steel Pipe Industry Of Indonesia
JK:ISSP
Indonesia Rp3.25 Trillion

Liability Composition Analysis (2013–2024)

This chart breaks down Oncoclinicas do Brasil's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Oncoclinicas do Brasil to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.12 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.06 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 7.23 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.85 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Oncoclinicas do Brasil's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Oncoclinicas do Brasil (2013–2024)

The table below shows the annual total liabilities of Oncoclinicas do Brasil from 2013 to 2024.

Year Total Liabilities Change
2024-12-31 R$7.82 Billion
≈ $1.53 Billion
+20.27%
2023-12-31 R$6.50 Billion
≈ $1.28 Billion
+16.37%
2022-12-31 R$5.59 Billion
≈ $1.10 Billion
+49.90%
2021-12-31 R$3.73 Billion
≈ $731.40 Million
+37.43%
2020-12-31 R$2.71 Billion
≈ $532.20 Million
+86.55%
2019-12-31 R$1.45 Billion
≈ $285.28 Million
+65.56%
2018-12-31 R$878.19 Million
≈ $172.32 Million
+58.52%
2017-12-31 R$553.99 Million
≈ $108.70 Million
+47.92%
2016-12-31 R$374.51 Million
≈ $73.49 Million
+14.68%
2015-12-31 R$326.58 Million
≈ $64.08 Million
-3.43%
2014-12-31 R$338.17 Million
≈ $66.35 Million
+24.20%
2013-12-31 R$272.27 Million
≈ $53.43 Million
--

About Oncoclinicas do Brasil

SA:ONCO3 Brazil Medical Care Facilities
Market Cap
$181.01 Million
R$922.52 Million BRL
Market Cap Rank
#17015 Global
#163 in Brazil
Share Price
R$1.05
Change (1 day)
-1.87%
52-Week Range
R$0.55 - R$3.72
All Time High
R$19.24
About

Oncoclínicas do Brasil Serviços Médicos S.A., together with its subsidiaries, provides oncology, hematology, radiotherapy, and genomics healthcare services in Latin America. The company offers treatment services, including radiotherapy, hormone therapy, immunotherapy, port-a-cath, palliative care, target therapy, breast cancer hormone therapy, bone marrow transplant, non-oncological infusions, ch… Read more